BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15675505)

  • 21. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.
    Stone SF; Price P; French MA
    HIV Med; 2005 Jul; 6(4):278-83. PubMed ID: 16011533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversion of immune escape HIV variants upon transmission: insights into effective viral immunity.
    Kent SJ; Fernandez CS; Dale CJ; Davenport MP
    Trends Microbiol; 2005 Jun; 13(6):243-6. PubMed ID: 15936652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human immunodeficiency virus pathogenesis and prospects for immune control in patients with established infection.
    Cohen DE; Walker BD
    Clin Infect Dis; 2001 Jun; 32(12):1756-68. PubMed ID: 11360218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune impairment thresholds in HIV infection.
    Iwami S; Nakaoka S; Takeuchi Y; Miura Y; Miura T
    Immunol Lett; 2009 Apr; 123(2):149-54. PubMed ID: 19428563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Host genetic factors that control immune responses to retrovirus infections.
    Miyazawa M; Tsuji-Kawahara S; Kanari Y
    Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modelling the influence of activation-induced apoptosis of CD4+ and CD8+ T-cells on the immune system response of a HIV-infected patient.
    Stan GB; Belmudes F; Fonteneau R; Zeggwagh F; Lefebvre MA; Michelet C; Ernst D
    IET Syst Biol; 2008 Mar; 2(2):94-102. PubMed ID: 18397120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of the immunological synapse: a key to HIV-1 pathogenesis?
    Fackler OT; Alcover A; Schwartz O
    Nat Rev Immunol; 2007 Apr; 7(4):310-7. PubMed ID: 17380160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
    Borghan MA; Oka S; Takiguchi M
    Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term highly active antiretroviral therapy in chronic HIV-1 infection: evidence for reconstitution of antiviral immunity.
    Jansen CA; Piriou E; De Cuyper IM; van Dort K; Lange JM; Miedema F; van Baarle D
    Antivir Ther; 2006; 11(1):105-16. PubMed ID: 16518966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-specific CD4+ T cells and viremia: who's in control?
    Jansen CA; van Baarle D; Miedema F
    Trends Immunol; 2006 Mar; 27(3):119-24. PubMed ID: 16458605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of HIV infection and antiretroviral therapy on hepatitis B virus (HBV)-specific T cell responses in patients who have resolved HBV infection.
    Lascar RM; Lopes AR; Gilson RJ; Dunn C; Johnstone R; Copas A; Reignat S; Webster G; Bertoletti A; Maini MK
    J Infect Dis; 2005 Apr; 191(7):1169-79. PubMed ID: 15747254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A dendritic cell-based vaccine for treating HIV infection: background and preliminary results.
    Andrieu JM; Lu W
    J Intern Med; 2007 Feb; 261(2):123-31. PubMed ID: 17241177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between Nef-specific CD8 T-cell responses and disease progression in HIV-1 subtype B infection.
    Jiao Y; Li TS; Xie J; Han Y; Qiu ZF; Zuo LY; Mourez T; Wang AX
    Chin Med J (Engl); 2006 Oct; 119(19):1609-15. PubMed ID: 17042973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rates of HIV immune escape and reversion: implications for vaccination.
    Davenport MP; Loh L; Petravic J; Kent SJ
    Trends Microbiol; 2008 Dec; 16(12):561-6. PubMed ID: 18964018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Of mice and men: cytotoxic T cells and AIDS pathogenesis.
    Klenerman P; Zinkernagel RM
    AIDS Read; 1999 Oct; 9(7):474-80. PubMed ID: 12737139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunopathogenesis and immunotherapy in AIDS virus infections.
    Letvin NL; Walker BD
    Nat Med; 2003 Jul; 9(7):861-6. PubMed ID: 12835706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What's new in HIV/AIDS. Protective immunity in HIV infection: where do we stand?
    Draenert R; Goebel FD
    Infection; 2004 Aug; 32(4):250-2. PubMed ID: 15293085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune defects in pediatric AIDS, their pathogenesis, and role of immunotherapy.
    Pahwa S
    Crit Care Med; 1990 Feb; 18(2 Suppl):S138-43. PubMed ID: 2153503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune control.
    Fornataro K; Jefferys R
    Body Posit; 1999 Mar; 12(3):9-12. PubMed ID: 11366299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV evolution and progression of the infection to AIDS.
    Huang G; Takeuchi Y; Korobeinikov A
    J Theor Biol; 2012 Aug; 307():149-59. PubMed ID: 22634206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.